Status:
COMPLETED
Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD
Lead Sponsor:
Virginia Commonwealth University
Conditions:
Alcohol Abuse
Alcohol Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Alcohol use and misuse are prevalent in the United States. Alcohol use disorder (AUD) is the most common substance use disorder. Evidence-based treatments are effective; however, most people with AUD ...
Detailed Description
Nationally, alcohol is the third leading preventable cause of death. In 2019, 14.1 million adults had an alcohol use disorder (AUD). However, most people with AUD do not receive treatment, and treatme...
Eligibility Criteria
Inclusion
- at least 18 years of age
- Male or female sex assigned at birth
- Meet DSM-5 Alcohol Use Disorder criteria
- report recent heavy alcohol use during the past month
- access to a smart mobile device or computer
- English-speaking.
- We are not excluding any participants based on gender identity.
Exclusion
- currently receiving specialized professional SUD treatment
- presenting with language barriers, cognitive impairment, or serious medical or psychiatric illness that would preclude them from providing informed consent or participating in the ResearchMatch.
Key Trial Info
Start Date :
April 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 22 2025
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT06190236
Start Date
April 10 2024
End Date
April 22 2025
Last Update
June 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298